Follow The Filings

ARCC Ares Capital

Ares Capital earnings company data as of 3:00 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS 0.48 — —
Rev — — —

Insider trades

Open-market buys and sales by ARCC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ARCC insider trades
  • $969K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Jana Markowicz COO
    Buy
    $288K 15,000 shares at $19.20 +147% to stake
    Traded Feb 9 Filed Feb 10
    ↗
  2. Michael Kort Schnabel CEO
    Buy
    $239K 12,500 shares at $19.13 +45% to stake
    Traded Feb 5 Filed Feb 9
    ↗
  3. Scott C Lem CFO
    Buy
    $100K 5,186 shares at $19.29 +15% to stake
    Traded Feb 6 Filed Feb 9
    ↗
  4. Mary Beth Henson Director
    Buy
    $77K 4,000 shares at $19.14 +14% to stake
    Traded Feb 5 Filed Feb 9
    ↗
  5. Michael Kort Schnabel CEO
    Buy
    $265K 13,000 shares at $20.39 +87% to stake
    Traded Oct 31, 2025 Filed Nov 3, 2025
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 1.01,2.03,8.01,9.01 Filing Doc
424B2 Filing Doc
424B2 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
424B2 Filing Doc
424B2 Filing Doc
424B2 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,1.02,9.01 Filing Doc
DEFA14A Filing Doc
10-K/A Filing Doc
DEF 14A FORM DEF 14A Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.